Status:
UNKNOWN
Parkinsonian Patients Treated With Apomorphine Pump: Observatory of Skin Lesions
Lead Sponsor:
University Hospital, Rouen
Conditions:
Patients With Parkinson's Disease Treated With Apomorphine Pumps
Eligibility:
All Genders
18+ years
Brief Summary
Treatment with subcutaneous apomorphine will be initiated according to the usual procedures at each centre. Once the patient is included in the study, he/she will be followed for 24 months according t...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years,
- Diagnosis of Parkinson's disease according to the MDS criteria (2015),
- Patients with a prescription for subcutaneous apomorphine pump therapy,
- Patient having read and understood the information letter and having expressed oral non-opposition to the research.
Exclusion
- Patient unable to express opposition or non-opposition,
- Patient not affiliated to the social security system,
- Pregnant woman or woman in labour or breastfeeding,
- Person deprived of liberty by an administrative or judicial decision,
- Person placed under court protection, guardianship or curatorship.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT05331573
Start Date
October 1 2020
End Date
October 1 2024
Last Update
September 1 2022
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amien
Amiens, France
2
CHU Caen
Caen, France
3
CH de Dreux
Dreux, France
4
CHRU Lille
Lille, France